On February 22, 2011, US Senator John Kerry and US Senator Scott Brown received a 3-page response from the FDA, per their joint letter about a DES apology. The FDA’s letter did not contain an official apology from the federal government for the DES drug disaster. However, it acknowledged the devastating health consequences of DES, explained FDA initiatives to prevent future drug disasters, and talked about DES as a “tragedy“.
The FDA closed the letter by writing, “We hope that our new tools for identifying, monitoring and mitigating drug risks will prevent other tragedies like those brought out by the widespread use of DES. We are committed to providing the public with timely and accurate drug safety information and we recognize the critical responsibility that the FDA has to protect the safety of the public’s health“.
- Image source: DES (Diethylstilbestrol) Info DES News on Facebook, 26 July 2012.
- FDA Response on DES Letter, WONDER DRUG Facebook album, 22 February 2011.
- The DES (Diethylstilbestrol) Drug Disaster, 40 Years Later: The Tragedy Is Far From Over, desinfo411, April 22, 2011.
- FDA Acknowledges, But Doesn’t Apologize For, DES Drug Disaster, desinfo411, April 19, 2011.
More DES DiEthylStilbestrol Resources
- DES studies on cancers and screening.
- DES studies on epigenetics and transgenerational effects.
- DES studies on fertility and pregnancy.
- DES studies on gender identity and psychological health.
- DES studies on in-utero exposure to DES and side-effects.
- DES studies on the genital tract.
- Papers on DES lawsuits.
- DES videos and posts tagged DES, the DES-exposed, DES victims.